Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world.

Intrapleural treatment can prolong the survival of NSCLC patients with MPE who do not receive targeted treatment or who only receive chemotherapy. The PE-CEA: B-CEA ratio can be used to predict the efficacy if intrapleural treatment is indicated.